Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference

Friday, November 7, 2008 General News
Email Print This Page Comment
Font : A-A+

MONTVALE, N.J., Nov. 6 Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that Michael Smith, Chief Financial Officer and Head of Business Development, will provide a company update at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, November 11, 2008 at 11:10 a.m. EST at the New York Palace Hotel, in New York City.



Interested parties may access the live webcast of the presentation by visiting the "Investors" section of Memory Pharmaceuticals' website at http://www.memorypharma.com. Archived versions of the webcast will be available at the same location for one week following the presentation.



About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.





SOURCE Memory Pharmaceuticals Corp.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook